✦ LIBER ✦

Human equilibrative nucleoside transporter 1 (hENT1): Do we really have a new predictive biomarker of chemotherapy outcome in pancreatic cancer patients?

✍ Scribed by Mohelnikova-Duchonova, Beatrice; Melichar, Bohuslav

Book ID: 123175083
Publisher: S. Karger AG
Year: 2013
Tongue: English
Weight: 260 KB
Volume: 13
Category: Article
ISSN: 1424-3903
DOI: 10.1016/j.pan.2013.09.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunohistochemical Analysis of Human Eq

Immunohistochemical Analysis of Human Equilibrative Nucleoside Transporter-1 (hENT1) Predicts Survival in Resected Pancreatic Cancer Patients Treated with Adjuvant Gemcitabine Monotherapy

✍ Soichiro Morinaga MD PhD,Yoshiyasu Nakamura… 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 459 KB

1987 EXPRESSION OF HUMAN EQUILIBRATIVE N

1987 EXPRESSION OF HUMAN EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1 (HENT1) IS A NOVEL PROGNOSIC MARKER IN ADVANCED BLADDER CANCER PATIENTS WITH GEMCITABINE-BASED CHEMOTHERAPY

✍ Matsumura, Nagahide; Nakamura, Yasushi; Nanpo, Yoshihito; Kodama, Yoshiki; Kikka 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 173 KB

161 EXPRESSION OF HUMAN EQUILIBRATIVE NU

161 EXPRESSION OF HUMAN EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1 (HENT1) IS A NOVEL PROGNOSIC MARKER IN ADVANCED BLADDER CANCER PATIENTS WITH GEMCITABINE-BASED CHEMOTHERAPY

✍ Matsumura, Nagahide; Nakamura, Yasushi; Nanpo, Yoshihito; Sasaki, Yumiko; Kodama 📂 Article 📅 2010 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 106 KB

Modeling interactions between human equi

Modeling interactions between human equilibrative nucleoside transporter-1 (hENT-1) and other factors involved in the response to gemcitabine treatment to predict of clinical outcomes, in pancreatic ductal adenocarcinoma (PDAC) patients.

✍ Pazienza, Valerio; Tavano, Francesca; Fontana, Andrea; Pellegrini, Fabio; France 📂 Article 📅 2014 🏛 S. Karger AG 🌐 English ⚖ 51 KB

Combined analysis of intratumoral human

Combined analysis of intratumoral human equilibrative nucleoside transporter 1 (hENT1) and ribonucleotide reductase regulatory subunit M1 (RRM1) expression is a powerful predictor of survival in patients with pancreatic carcinoma treated with adjuvant gemcitabine-based chemotherapy after operative resection

✍ Nakagawa, Naoya; Murakami, Yoshiaki; Uemura, Kenichiro; Sudo, Takeshi; Hashimoto 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 842 KB